FDA approvals in 2025 introduced novel therapies and devices across ophthalmic subspecialties, emphasizing sustained efficacy ...
Forbes contributors publish independent expert analyses and insights. This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback